1. Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report.
- Author
-
Bardi M, Arnoldi E, Pizzocchero G, Pezzica E, Mattioni D, and Perotti M
- Subjects
- Breast Neoplasms surgery, Carcinoma, Ductal, Breast surgery, Carcinoma, Endometrioid surgery, Chemotherapy, Adjuvant, Endometriosis surgery, Female, Humans, Hysterectomy, Leiomyoma surgery, Middle Aged, Ovarian Neoplasms surgery, Ovariectomy, Tamoxifen therapeutic use, Uterine Neoplasms surgery, Breast Neoplasms drug therapy, Carcinoma, Ductal, Breast drug therapy, Carcinoma, Endometrioid etiology, Endometriosis etiology, Leiomyoma etiology, Ovarian Neoplasms etiology, Tamoxifen adverse effects, Uterine Neoplasms etiology
- Abstract
This concerns a 57 year old woman operated on in 1988 for a left radical mastectomy due to ductal breast carcinoma and subsequently treated with chemotherapy and Tamoxifen adjuvant. In 1990 a laparo-hystero-oophorectomy was carried out due to uterine fibromas. The woman continued taking Tamoxifen. Two years later a pelvic regeneration appeared, resulting in endometriosis, site of adenomatose hyperplasia and of endometrioid carcinoma GI. This furthermore confirms the importance of a gynecological follow-up for all women treated with Tamoxifen adjuvant therapy.
- Published
- 1994